Coryse Borg speaks to Robert Smith, Director of Smiro Qualitas Ltd, an independent pharmaceutical consultancy firm, about the strategic reasons behind establishing a presence in Malta, the gaps in the country’s clinical-trial landscape, and how targeted investment could unlock long-term value for patients, companies and the wider economy.What inspired Smiro Qualitas to establish a dedicated...
